WO1995023973A3 - Dosage immunologique vih a l'aide de proteines recombinantes et de reactifs peptidiques de synthese - Google Patents

Dosage immunologique vih a l'aide de proteines recombinantes et de reactifs peptidiques de synthese Download PDF

Info

Publication number
WO1995023973A3
WO1995023973A3 PCT/US1995/002195 US9502195W WO9523973A3 WO 1995023973 A3 WO1995023973 A3 WO 1995023973A3 US 9502195 W US9502195 W US 9502195W WO 9523973 A3 WO9523973 A3 WO 9523973A3
Authority
WO
WIPO (PCT)
Prior art keywords
recombinant protein
synthetic peptide
hiv
utilizing recombinant
immunoassay utilizing
Prior art date
Application number
PCT/US1995/002195
Other languages
English (en)
Other versions
WO1995023973A2 (fr
Inventor
James L Gallarda
Barbara L Stone
Douglas J Liu
Susan K Harrington
George J Dawson
Ping Wu
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Priority to AU18809/95A priority Critical patent/AU1880995A/en
Priority to EP95911077A priority patent/EP0698214A1/fr
Priority to JP7522932A priority patent/JPH08510063A/ja
Publication of WO1995023973A2 publication Critical patent/WO1995023973A2/fr
Publication of WO1995023973A3 publication Critical patent/WO1995023973A3/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • AIDS & HIV (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention concerne un dosage pour détecter simultanément la présence d'anticorps du VIH-1 et/ou du VIH-2 dans un échantillon pour essai. Les analytes sont capturés en phases solides soit identiques soit différentes, et la présence desdits analytes est déterminée par la détection d'un signal généré au moyen d'un cocktail de réactifs indicateurs contenant des antigènes obtenus par synthèse ou par recombinaison.
PCT/US1995/002195 1994-03-02 1995-02-21 Dosage immunologique vih a l'aide de proteines recombinantes et de reactifs peptidiques de synthese WO1995023973A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU18809/95A AU1880995A (en) 1994-03-02 1995-02-21 Hiv immunoassay utilizing recombinant protein and synthetic peptide reagents
EP95911077A EP0698214A1 (fr) 1994-03-02 1995-02-21 Dosage immunologique vih a l'aide de proteines recombinantes et de reactifs peptidiques de synthese
JP7522932A JPH08510063A (ja) 1994-03-02 1995-02-21 リコンビナントタンパクおよび合成ペプチド試薬を用いるｈｉｖイムノアッセイ

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20470394A 1994-03-02 1994-03-02
US08/204,703 1994-03-02

Publications (2)

Publication Number Publication Date
WO1995023973A2 WO1995023973A2 (fr) 1995-09-08
WO1995023973A3 true WO1995023973A3 (fr) 1995-09-28

Family

ID=22759076

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1995/002195 WO1995023973A2 (fr) 1994-03-02 1995-02-21 Dosage immunologique vih a l'aide de proteines recombinantes et de reactifs peptidiques de synthese

Country Status (5)

Country Link
EP (1) EP0698214A1 (fr)
JP (1) JPH08510063A (fr)
AU (1) AU1880995A (fr)
CA (1) CA2161872A1 (fr)
WO (1) WO1995023973A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020122A (en) * 1995-06-07 2000-02-01 Abbott Laboratories Hepatitis C virus second envelope (HCV-E2) glycoprotein expression system
US6846905B2 (en) 1997-08-15 2005-01-25 Abbott Laboratories Antigen constructs useful in the detection and differentiation of antibodies to HIV
US5922533A (en) * 1997-08-15 1999-07-13 Abbott Laboratories Rapid assay for simultaneous detection and differentiation of antibodies to HIV groups
EP1091976A2 (fr) * 1998-07-02 2001-04-18 Peptide Solutions, Inc. Peptides du virus varicelle-zona et autres virus permettant d'assurer un diagnostic et une therapie dans le cas du vih-2
JP3536731B2 (ja) * 1999-07-28 2004-06-14 富士レビオ株式会社 ＨＩＶ−１ｐ２４抗原の免疫測定方法及び試薬
US6818392B2 (en) 2000-12-06 2004-11-16 Abbott Laboratories Monoclonal antibodies to human immunodeficiency virus and uses thereof
AU2002317755A1 (en) * 2001-05-25 2002-12-09 Bsh Bosch Und Siemens Hausgerate Gmbh Heat status display for a gas cooker point
FR2839555B1 (fr) 2002-05-10 2007-07-27 Bio Rad Pasteur Procede de detection simultanee d'un antigene et d'un anticorps d'un microorganisme infectieux
EP4374790A3 (fr) 2009-04-30 2024-07-31 DexCom, Inc. Rapports de performances associés à des données de détecteur continues à partir de périodes multiples de temps d'analyse
EP2856163B1 (fr) * 2012-05-30 2016-07-06 Bio-Rad Innovations Procédé permettant de diagnostiquer et de différencier les infections du hiv-2
AU2015328129B2 (en) * 2014-10-08 2022-06-02 Avioq, Inc. Methods for simultaneous determination of serological profile and estimation of duration post HIV infection
SG10201505838PA (en) * 2015-07-27 2017-02-27 Mp Biomedicals Asia Pacific Pte Ltd Method and kit

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992000997A1 (fr) * 1990-07-09 1992-01-23 Biochem Pharma Inc. Peptides de synthese et leurs melanges servant a detecter des anticorps anti-vih
WO1992001713A1 (fr) * 1990-07-18 1992-02-06 Biochem Pharma Inc. Peptides et analogues et leurs melanges servant a detecter des anticorps agissant contre les virus htlv-i et htlv-ii
WO1993009252A1 (fr) * 1991-11-04 1993-05-13 Baxter Diagnostics Inc. Peptides synthetiques correspondant a des portions du virus vih-2 et procedes d'utilisation de ces peptides dans une analyse amelioree
WO1993021346A1 (fr) * 1992-04-09 1993-10-28 Abbott Laboratories Dosage pour la detection de l'antigene du vih et de l'anticorps du vih

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992000997A1 (fr) * 1990-07-09 1992-01-23 Biochem Pharma Inc. Peptides de synthese et leurs melanges servant a detecter des anticorps anti-vih
WO1992001713A1 (fr) * 1990-07-18 1992-02-06 Biochem Pharma Inc. Peptides et analogues et leurs melanges servant a detecter des anticorps agissant contre les virus htlv-i et htlv-ii
WO1993009252A1 (fr) * 1991-11-04 1993-05-13 Baxter Diagnostics Inc. Peptides synthetiques correspondant a des portions du virus vih-2 et procedes d'utilisation de ces peptides dans une analyse amelioree
WO1993021346A1 (fr) * 1992-04-09 1993-10-28 Abbott Laboratories Dosage pour la detection de l'antigene du vih et de l'anticorps du vih

Also Published As

Publication number Publication date
JPH08510063A (ja) 1996-10-22
EP0698214A1 (fr) 1996-02-28
WO1995023973A2 (fr) 1995-09-08
CA2161872A1 (fr) 1995-09-08
AU1880995A (en) 1995-09-18

Similar Documents

Publication Publication Date Title
WO1999009410A3 (fr) Titrage rapide pour la detection et la differenciation simultanees d'anticorps contre le vih
DE69434285D1 (de) Lyophilisierte ligand-rezeptor komplexe zum nachweis und als sensoren
DE69714584D1 (de) Immunoassays zum nachweis von antiphospholipid-antikörpern
EP0154884A3 (fr) Produit conjugué d'acide nucléique et protéine
WO1995023973A3 (fr) Dosage immunologique vih a l'aide de proteines recombinantes et de reactifs peptidiques de synthese
TW370614B (en) Oligomerized antibodies, method of immunological determination using the same and reagent kit comprising the same
CA2285919A1 (fr) Tests et trousses de diagnostic pour clostridium difficile
ATE80735T1 (de) Kolorimetrisches immunoessay auf fester oberflaeche, sowie dazu zu verwendender teststab und seine herstellung.
CA2188752A1 (fr) Dosage immunologique de l'homocysteine
EP1475442A3 (fr) Polypeptides de l'antivirus lymphotropiques de cellules t du chat
EP1318401A3 (fr) Méthode pour la détection précoce de la séroconversion d'un anticorps contre l'hépatite C virus
CA2007336A1 (fr) Test de diagnostic fait au moyen d'anticorps chimeriques
KR950008537A (ko) 엡스타인 바 비루스(ebv)에 대한 항체의 검출용 진단제
CA2048655A1 (fr) Methode de differenciation des anticorps anti htlv-1, htlv-ii et des anticorps diriges contres des retrovirus connexes, nouveaux peptides, trousses de detection des anticorpset dedosage immunologique
CA2117378A1 (fr) Dosage et methode de detection de htlv-i/htlv-ii
EP0346119A3 (fr) Essai anti-FC pour détecter des anticorps
EP0806669A3 (fr) Réactif diagnostique pour infection par le virus de l'hépatite C
NZ334809A (en) Assay for the detection of antibodies against p53
EP0242589A3 (fr) Détection d'haptènes dans des techniques d'immunoessai
EP0245052A3 (fr) Détection d'inflammation et anticorps à cet effet
IE870498L (en) Competitive elisa for detection of antibodies
CA2213083A1 (fr) Detection de la production d'anticorps
ATE143142T1 (de) Immunoassay zum nachweis von antikörpern gegen hiv
RU97115554A (ru) Обнаружение продуцирования антител
EP0268465A3 (fr) Procédé pour la détection de la présence d'un antigène de plante dans une plante

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 2161872

Country of ref document: CA

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1995911077

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1995911077

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1995911077

Country of ref document: EP